Puretech Health
PureTech Health, a pioneering biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for complex diseases. Founded in 2015, PureTech has established itself as a leader in the healthcare industry, with a strong emphasis on advancing drug development in areas such as neuroscience, immunology, and gastrointestinal health. The company is renowned for its unique approach to drug discovery, leveraging its proprietary platform to identify and develop novel therapeutics. With a robust pipeline of products, including treatments for neurodegenerative disorders and immune-mediated diseases, PureTech Health is well-positioned in the market. Its commitment to addressing unmet medical needs has garnered recognition, making it a notable player in the biopharmaceutical landscape.
DitchCarbon Score
How does Puretech Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Puretech Health's score of 38 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Puretech Health's reported carbon emissions
In 2023, Puretech Health reported total carbon emissions of approximately 276,200 kg CO2e. This figure includes 3,900 kg CO2e from Scope 1 emissions, 57,000 kg CO2e from Scope 2 emissions (market-based), and 107,700 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 168,500 kg CO2e. Comparatively, in 2022, the company’s total emissions were significantly higher at about 665,000 kg CO2e, with Scope 1 emissions at 10,600 kg CO2e, Scope 2 emissions (market-based) at 402,600 kg CO2e, and Scope 3 emissions at 251,900 kg CO2e. This indicates a substantial reduction in total emissions year-on-year. In 2021, Puretech Health's total emissions were approximately 464,300 kg CO2e, with Scope 1 emissions at 116,400 kg CO2e, Scope 2 emissions (market-based) at 134,100 kg CO2e, and Scope 3 emissions at 329,600 kg CO2e. The trend shows a consistent effort towards reducing emissions over the years. Despite these reductions, there are currently no specific reduction targets or climate pledges disclosed by Puretech Health. The company has not outlined any science-based targets or commitments to further reduce its carbon footprint, indicating a potential area for future improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 25,900 | 000,000 | 00,000 | 0,000 |
| Scope 2 | 120,900 | 000,000 | 000,000 | 00,000 |
| Scope 3 | 232,700 | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Puretech Health is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
